{"id":"W4411469637","doi":"10.1016/j.eururo.2025.05.037","title":"Postprogression Survival of Patients with Metastatic Hormone-sensitive Prostate Cancer who Received Darolutamide or Placebo in Combination with Docetaxel and Androgen Deprivation Therapy: Post Hoc Analysis of the Phase 3 ARASENS Trial","year":2025,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Bayer","keywords":"Medicine; Docetaxel; Taxane; Hazard ratio; Internal medicine; Discontinuation; Prostate cancer; Placebo; Androgen deprivation therapy; Oncology; Post-hoc analysis; Surgery; Chemotherapy; Cancer; Confidence interval; Breast cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003631672,0.0001399422,0.0004501112,0.0003646543,0.00005428571,0.00000760279,0.0000621724,0.00002652497,0.000007713463],"category_scores_gemma":[0.00009156022,0.00006957867,0.00004258716,0.0009506337,0.0002595031,0.00005537093,0.00004338599,0.0001354976,1.904917e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004713814,"about_ca_system_score_gemma":0.0001800303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006809653,"about_ca_topic_score_gemma":0.0002149679,"domain_scores_codex":[0.998368,0.0006634993,0.0002929233,0.0002626427,0.0002421237,0.0001708642],"domain_scores_gemma":[0.9989836,0.0001740594,0.0002493292,0.0002021523,0.0003515114,0.00003931784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6818401,0.001199437,0.2976538,0.00004402435,0.002064833,0.0000580708,0.001798141,0.0001107501,0.002653031,0.00001410352,0.00001384942,0.01254983],"study_design_scores_gemma":[0.1623762,0.0104481,0.8233428,0.00007894911,0.001072451,0.000001369556,0.0001900766,0.0005669785,0.001785281,0.000005573777,0.00005338404,0.00007888205],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966478,0.0004435812,0.0000219506,0.0008209122,0.00003120368,0.001764712,0.0001275256,0.00000848769,0.0001338214],"genre_scores_gemma":[0.9990129,0.0004820392,0.0000415236,0.0001030596,0.000005990131,0.00002698575,0.0001994488,0.00001578728,0.0001122246],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.525689,"threshold_uncertainty_score":0.2837335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01883576807794882,"score_gpt":0.3126071092349026,"score_spread":0.2937713411569538,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}